Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 999 

    Article Cited by others

ORIGINAL ARTICLE

Serum TGF-β, Serum MMP-1, and HOMA-IR as non-invasive predictors of fibrosis in Egyptian patients with NAFLD

Mahmoud Adel A, Bakir Amal S, Shabana Sherif S

Year : 2012| Volume: 18| Issue : 5 | Page no: 327-333

   This article has been cited by
 
1 Hepatocyte TGF-ß Signaling Inhibiting WAT Browning to Promote NAFLD and Obesity Is Associated With Let-7b-5p
Jinfang Zhao, Lilin Hu, Wenfang Gui, Li Xiao, Weijun Wang, Jing Xia, Huiqian Fan, Zhonglin Li, Qingjing Zhu, Xiaohua Hou, Huikuan Chu, Ekihiro Seki, Ling Yang
Hepatology Communications. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 TGF-ß1 signaling can worsen NAFLD with liver fibrosis backdrop
Hammad Ahmed, Muhammad Ihtisham Umar, Salman Imran, Faraza Javed, Shahzada Khurram Syed, Romana Riaz, Waseem Hassan
Experimental and Molecular Pathology. 2021; : 104733
[Pubmed]  [Google Scholar] [DOI]
3 Target Deconvolution of Fenofibrate in Nonalcoholic Fatty Liver Disease Using Bioinformatics Analysis
Ali Mahmoudi, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar, Bing Niu
BioMed Research International. 2021; 2021: 1
[Pubmed]  [Google Scholar] [DOI]
4 Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque
Frontiers in Medicine. 2021; 8
[Pubmed]  [Google Scholar] [DOI]
5 The acute effect of metabolic cofactor supplementation: a potential therapeutic strategy against non-alcoholic fatty liver disease
Cheng Zhang, Elias Bjornson, Muhammad Arif, Abdellah Tebani, Alen Lovric, Rui Benfeitas, Mehmet Ozcan, Kajetan Juszczak, Woonghee Kim, Jung Tae Kim, Gholamreza Bidkhori, Marcus Ståhlman, Per-Olof Bergh, Martin Adiels, Hasan Turkez, Marja-Riitta Taskinen, Jim Bosley, Hanns-Ulrich Marschall, Jens Nielsen, Mathias Uhlén, Jan Borén, Adil Mardinoglu
Molecular Systems Biology. 2020; 16(4)
[Pubmed]  [Google Scholar] [DOI]
6 Insulin resistance in nondiabetic Egyptian patients with chronic hepatitis C virus
M.A. Shawky, A.Q. Mohammed, A.M. Hassan, B.H. Ali, H.M. Moustafa
Revista de Gastroenterología de México (English Edition). 2020; 85(2): 173
[Pubmed]  [Google Scholar] [DOI]
7 Investigating fibrosis and inflammation in an ex vivo NASH murine model
Emilia Gore, Emilia Bigaeva, Anouk Oldenburger, Yvette J. M. Jansen, Detlef Schuppan, Miriam Boersema, Jörg F. Rippmann, Andre Broermann, Peter Olinga
American Journal of Physiology-Gastrointestinal and Liver Physiology. 2020; 318(2): G336
[Pubmed]  [Google Scholar] [DOI]
8 Burden of Disease due to Nonalcoholic Fatty Liver Disease
Mark D. Muthiah, Arun J. Sanyal
Gastroenterology Clinics of North America. 2020; 49(1): 1
[Pubmed]  [Google Scholar] [DOI]
9 Effects of green coffee extract supplementation on glycemic indexes, leptin, and obesity values in patients with non-alcoholic fatty liver disease
Samaneh Hosseinabadi, Maryam Rafraf, Abolfazl Mahmoodzadeh, Mohammad Asghari-Jafarabadi, Somayyeh Asghari
Journal of Herbal Medicine. 2020; 22: 100340
[Pubmed]  [Google Scholar] [DOI]
10 A high ratio of dietary n-3/n-6 polyunsaturated fatty acids improves obesity-linked inflammation and insulin resistance through suppressing activation of TLR4 in SD rats
Han-Qiang Liu,Ya Qiu,Ying Mu,Xian-Jiao Zhang,Lu Liu,Xiang-Hong Hou,Lei Zhang,Xiao-Na Xu,Ai-Ling Ji,Rui Cao,Rui-Hua Yang,Feng Wang
Nutrition Research. 2013; 33(10): 849
[Pubmed]  [Google Scholar] [DOI]
11 APRI, the FIB-4 score, and Forn’s index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B
Fatma Ucar,Sevilay Sezer,Zeynep Ginis,Gulfer Ozturk,Aynur Albayrak,Omer Basar,Fuat Ekiz,Sahin Coban,Osman Yuksel,Ferah Armutcu,Erdem Akbal
European Journal of Gastroenterology & Hepatology. 2013; 25(9): 1076
[Pubmed]  [Google Scholar] [DOI]

 

Read this article